TOURMALINE BIO INC (TRML) Stock Cash Flow
NASDAQ:TRML - Nasdaq - US89157D1054 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -82.87M | -73.21M | -42.12M | -73.89M | -47.83M | |||
| Depreciation Amortization | 41.00K | 39.00K | 33.00K | 1.38M | 620.00K | |||
| Change In Working Capital | -818.00K | -3.15M | -168.00K | 1.10M | 2.32M | |||
| Other non cash items | -373.00K | -938.00K | 14.18M | 10.56M | 4.91M | |||
| OPERATING CASH FLOW | -84.02M | -77.26M | -28.08M | -60.86M | -39.99M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -18.00K | -9.00K | -56.00K | -3.04M | -2.44M | |||
| Other Investing Activity | 20.52M | -194.30M | 3.90M | 58.71M | -93.95M | |||
| INVESTING CASH FLOW | 20.50M | -194.31M | 3.84M | 55.67M | -96.39M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | -4.00K | 91.97M | 240.00K | 137.68M | |||
| Other Financing Activity | 0.00 | 161.35M | 64.75M | 0.00 | -280.00K | |||
| FINANCING CASH FLOW | 558.00K | 161.35M | 156.72M | 240.00K | 137.40M | |||
| CHANGE IN CASH | -62.96M | -110.22M | 132.48M | -4.95M | 1.02M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -84.02M | -77.26M | -28.08M | -60.86M | -39.99M | |||
| Capital Expenditure | -18.00K | -9.00K | -56.00K | -3.04M | -2.44M | |||
| FREE CASH FLOW | -84.04M | -77.27M | -28.14M | -63.90M | -42.43M | |||
All data in USD